Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2024/08/072215
CTRI/2024/08/072215
Not yet recruiting
Phase 2

A prospective clinical study to determine the therapeutic dose of Centchroman in the manangement of cyclical mastalgia - NI

ttar Pradesh University of Medical Sciences0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Health Condition 1: M95-M95- Other disorders of the musculoskeletal system and connective tissue
Sponsor
ttar Pradesh University of Medical Sciences
Status
Not yet recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Sponsor
ttar Pradesh University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • •All women with mastalgia with VAS score \=3 lasting for more than 5\-7 days per cycle were included after signing a consent form.

Exclusion Criteria

  • •Patients with polycystic ovarian diseases and uterine cervical hyperplasia.
  • •First six months of Lactation and pregnancy
  • •Patients who were not giving consent.
  • •Past history of breast carcinoma or family history of breast carcinoma
  • •Patient who were planning for pregnancy .
  • •Women suspected or diagnosed of malignancy
  • •Recent history of jaundice or hepatic impairment.
  • •Severe allergic states.
  • •History of thrombosis.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A prospective clinical study to evaluate the feasibility and safeness of the chemotherapy with weekly paclitaxel administration in cases with anaplastic thyroid cancer
JPRN-UMIN000008574Anaplastic Thyroid Carcinoma Consortium Japan50
Completed
Not Applicable
Can yoga reduce the need of medication after surgery?Health Condition 1: null- Cholelithiasis
CTRI/2018/01/011355self funded452
Not yet recruiting
Not Applicable
tility of homoeopathic medicines in Bedwetting in childreHealth Condition 1: N394- Other specified urinary incontinence
CTRI/2024/05/067328RAJKOT HOMOEOPATHIC MEDICAL COLLEGE PARUL UNIVERSITY
Not yet recruiting
Not Applicable
Identification of clinically relevant biomarkers for early detection of progression analysis of NAFLD to NASH
CTRI/2023/12/060718Strand Life Sciences Private Limited
Not yet recruiting
Not Applicable
A prospective study to investigate clinical factors predicting hepatocarcinogenesis after the eradication of hepatitis C virus.hepatocellular carcinoma
JPRN-UMIN000028448Kyoto University400